BCBA/CAH (BCBA/CAH)

Buenos Aires Stock Exchange: BCBA/CAH · ARS

ARS 135,700

-1578.71 (-1.1%)· Recorded snapshot

Market cap	87.8T
Revenue (ttm)	376.7T
Net income (ttm)	2.5T
EPS (ttm)	ARS 3,707
P/E (trailing)	36.6x
P/E (forward)	19.5x
Dividend	ARS 632 (0.47%)
Volume	55

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 376.7T
Net income (ttm): 2.5T
EPS (ttm): ARS 3,707
P/E (trailing): 36.6x
P/E (forward): 19.5x
Market cap: 87.8T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E19.5

P25 15P50 18.3P75 23.8

Trailing P/E36.6

P25 25.1P50 32.2P75 41.5

ROEn/a

P25 5P50 10.6P75 23.5

ROIC18.4

P25 7.2P50 13.5P75 19.8

Benchmarks · 1M

All BCBA/CAH indicators

Market & fundamental data

Available fields

243

Groups with data

Currency

USD

Showing 243 of 243 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-11-05
Employees	61,344
Employees change	6,200
Employees growth	10.75%
Enterprise value	ARS 95.9T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	1979
Industry	Medical Distribution
Is primary listing	No
ISIN number	ARDEUT110798
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Last stock split date	2001-04-23
Last stock split type	Forward
Market cap	ARS 87.8T
Next earnings date	2026-11-05
Price	ARS 135,700.00
Price currency	ARS
Sector	Healthcare
SIC code	5122
Stock price date	2026-10-27
Symbol	bcba/CAH
Website	https://www.cardinalhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	181.56x
Average P/E ratio (3Y)	34.74x
Average P/E ratio (5Y)	35.65x
Earnings yield	2.73%
EV/Earnings	37.78x
EV/EBIT	18.97x
EV/EBITDA	13.74x
EV/FCF	14.31x
EV/Sales	0.25x
FCF / EV yield	6.99%
FCF yield	7.64%
Forward P/E	19.5x
Lynch fair value	ARS 89,939.30
Lynch upside	-33.72%
P/(FCF - SBC) ratio	14.25x
P/(OCF - SBC) ratio	12.33x
P/E ratio	36.6x
P/FCF ratio	13.09x
P/OCF ratio	11.45x
P/S ratio	0.23x
Price/EBITDA ratio	13.96x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	1.29%
EBITDA margin	1.67%
Effective tax rate	21.57%
FCF margin	1.71%
Gross margin	3.84%
Operating margin	1.29%
Pretax margin	0.86%
Profit margin	0.67%
Profit per employee	ARS 41.4M
Profitable quarters	11
Profitable years	4
Revenue per employee	ARS 6.1B
ROA	3.72%
ROA (5Y)	2.96%
ROCE	24.55%
ROIC	18.36%
ROIC (5Y)	15.17%
SBC / revenue	0.14%
Tax / revenue	0.18%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	12.09%
EPS growth (Q)	68.8%
EPS growth (QoQ)	-0.54%
EPS growth 10Y	5.28%
EPS growth 3Y	79.03%
EPS growth 5Y	28.3%
EPS growth quarters	1
EPS growth years	4
FCF growth	144.6%
FCF growth (Q)	10.87%
FCF growth (QoQ)	-14.85%
FCF growth 3Y	24.18%
FCF growth 5Y	17.4%
Gross profit growth	19.66%
Gross profit growth (Q)	16.26%
Gross profit growth 3Y	12.45%
Gross profit growth 5Y	7.6%
Net income growth	9.8%
Net income growth (Q)	66.53%
Net income growth (QoQ)	-0.25%
Net income growth 3Y	73.18%
Net income growth 5Y	22.91%
Net income growth quarters	1
Net income growth years	4
OCF growth	115.85%
OCF growth (Q)	11.32%
OCF growth (QoQ)	-7.19%
OCF growth 10Y	5.7%
OCF growth 3Y	22.08%
OCF growth 5Y	16.33%
Operating income growth	32.26%
Operating income growth (Q)	34.02%
Operating income growth 3Y	22.49%
Operating income growth 5Y	12.88%
Revenue growth	14.23%
Revenue growth (Q)	5.84%
Revenue growth (QoQ)	4.48%
Revenue growth 10Y	7.66%
Revenue growth 3Y	7.44%
Revenue growth 5Y	9.37%
Revenue growth quarters	6
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	ARS -961.5B
Depreciation and amortization	ARS 1.5T
EBIT	ARS 4.9T
EBITDA	ARS 6.3T
EPS	ARS 3,707.18
Financing cash flow	ARS -2.4T
Free cash flow	ARS 6.7T
Free cash flow minus SBC	ARS 6.2T
Gross profit	ARS 14.5T
Income taxes	ARS 694.8B
Investing cash flow	ARS -3.8T
Net borrowing	ARS 518.4B
Net cash flow	ARS 1.5T
Net income	ARS 2.5T
Operating cash flow minus SBC	ARS 7.1T
Operating income	ARS 4.9T
Revenue	ARS 376.7T
Stock-based compensation	ARS 543.7B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.02
Book value per share	ARS -18,331.18
Debt / EBITDA	2.2
Debt / FCF	2.21
Goodwill	ARS 17.6T
Interest coverage	9.45
Long-term assets	ARS 25.3T
Long-term liabilities	ARS 21.4T
Net cash (debt)	ARS -7.6T
Net cash / market cap	-8.68%
Net debt / EBITDA	1.21
Net debt / FCF	1.14
Piotroski F-Score	7
Property, plant and equipment	ARS 6.2T
Shareholders' equity	ARS -4T
Tangible book value	ARS -24.5T
Tangible book value per share	ARS -105,002.11
Total assets	ARS 84.9T
Total cash	ARS 7.2T
Total debt	ARS 14.8T
Total liabilities	ARS 88.9T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	4.61
Current assets	ARS 59.6T
Current liabilities	ARS 67.5T
Current ratio	0.88
Inventory turnover	14.33
Net working capital	ARS -11.7T
Quick ratio	0.43
Working capital	ARS -7.6T
Working capital turnover	-98,154.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.07%
Dividend growth	26.34%
Dividend growth (10Y)	62.33%
Dividend growth (3Y)	75.48%
Dividend growth (5Y)	76.23%
Dividend growth years	14
Dividend payment date	2026-10-15
Dividend payment years	27
Dividend payout frequency	Quarterly
Dividend per share	ARS 631.66
Dividend yield	0.47%
Ex-dividend date	2026-10-01
Last dividend	ARS 165.76
Payout ratio	28.65%
Shareholder yield	2.53%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	ARS 115,145.17
1D price change	-1.15%
1M price change	14.11%
1M total return	14.36%
1W price change	-0.88%
1W total return	-0.88%
1Y price change	60.97%
1Y return CAGR	62.06%
1Y total return	62.01%
20-day SMA	ARS 130,191.25
200-day SMA	ARS 113,250.38
3M price change	11.64%
3M total return	11.89%
3Y price change	412.07%
3Y return CAGR	73.72%
3Y total return	424.46%
50-day SMA	ARS 126,687.50
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 141,700.00
52-week high date	2026-10-22
52-week low	ARS 76,500.00
52-week low date	2025-10-27
5Y price change	4,079.24%
5Y return CAGR	112.84%
5Y total return	4,265.92%
6M price change	36.93%
6M total return	37.41%
All-time high	ARS 141,700.00
All-time high date	2026-10-22
All-time low	ARS 2,426.50
All-time low date	2021-02-18
Average true range (ATR)	ARS 2,446.78
Average volume	257.2
Change from 52-week high	-4.23%
Change from 52-week low	77.39%
Change from all-time high	-4.23%
Change from all-time low	5,492.42%
Change from open	-1.86%
Day's gap	0.73%
Dollar volume	ARS 7.5M
High price	ARS 138,275.00
Low price	ARS 135,700.00
Monthly RSI	77.08
Open price	ARS 138,275.00
Position in 52-week range	0%
Previous close	ARS 137,275.00
Price vs 150-day SMA	17.85%
Price vs 20-day SMA	4.23%
Price vs 200-day SMA	19.82%
Price vs 50-day SMA	7.11%
Relative volume	0.21
RSI	61.79
Sharpe ratio	1.77
Sharpe ratio (3Y)	1.6
Sharpe ratio (5Y)	1.93
Sortino ratio	3.32
Sortino ratio (3Y)	2.72
Sortino ratio (5Y)	3.26
Volume	55
Weekly RSI	66.49
YTD price change	28.69%
YTD total return	29.51%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	231.1M
Shares change (QoQ)	-0.42%
Shares change (YoY)	-2.07%
Shares held by insiders	0.08%
Shares held by institutions	90.6%
Short ratio	4.2 days

Deeper analysis on BCBA/CAH

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/CAH report

Is a complete BCBA/CAH research report available?

No complete published report is available for bcba/CAH (BCBA/CAH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/CAH (BCBA/CAH)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/CAH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/CAH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/CAH

Frequently asked questions